(www.theguardian.com)

275 points swores | 1 comments | 25 Apr 24 12:25 UTC | HN request time: 0.256s | source

Show context

squigz ◴[26 Apr 24 20:02 UTC] No.40173571[source]▶

For those in favor of drug companies charging exorbitant amounts of money for life-saving medication in order to recoup their R&D costs (and we'll be generous and believe their reasoning and numbers)... it follows that, once they've recouped their costs, they should lower the price, right?

replies(3): >>40173700 #>>40173741 #>>40173751 #

1. aantix ◴[26 Apr 24 20:18 UTC] No.40173751[source]▶

>>40173571 #

No.

Because there are infinite hypotheses for drug improvement, disease management, and cure.

And for the company to pursue that research, they need to capitalize on current successes.

The company needs to be able to survive in downturns.

Just like any company.

↑

Cost of developing new drugs may be lower than industry claims: trial